期刊
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
卷 40, 期 18, 页码 8332-8339出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2021.1911853
关键词
Curcumin; didemethylcurcumin; proteasome; molecular docking; neurodegeneration; cancer
资金
- Intramural Research Program of The Rockefeller Neuroscience Institute at West Virginia University, Morgantown, WV
- National Institutes of Health [1R01 AA022414]
Curcumin and its synthetic polyphenolic derivative, didemethylcurcumin, modulate proteasome activity in a biphasic manner. Curcumin increases proteasome activity at nanomolar concentrations but inhibits it at micromolar concentrations. Docking simulations show that curcumin has a stronger binding interaction with the proteasome compared to CUIII, suggesting their potential as therapeutic agents for neurodegeneration and cancer.
Modulation of proteasome function by pharmacological interventions and molecular biology tools is an active area of research in cancer biology and neurodegenerative diseases. Curcumin (diferuloylmethane) is a naturally occurring polyphenol that affects multiple signaling pathways. Curcumin shows anti-inflammatory, antioxidant, anti-angiogenic, or anti-apoptotic properties. Recent research suggests that the therapeutic efficacy of curcumin may be due to its activity as a potent inhibitor of the proteasome. Using in vitro cell culture and molecular docking methods, here we show that both curcumin and its synthetic polyphenolic derivative (didemethylcurcumin, CUIII) modulated proteasome activity in a biphasic manner. Curcumin and CUIII increased proteasome activity at nanomolar concentrations, but inhibited proteasome activity at micromolar concentrations. Curcumin was more effective than CUIII in increasing relative proteasome activity at nanomolar concentrations. Also, curcumin was more effective than CUIII in inhibiting relative proteasome activity at micromolar concentrations. Docking simulations of curcumin and didemethylcurcumin binding to the 20S proteasome catalytic subunit estimated K (d) values of 0.0054 mu M and 1.3167 mu M, respectively. These values correlate well with the results of the effectiveness of modulation by curcumin compared to CUIII. The small size of CUIII allows it to dock to the narrow cavity of the active site, but the binding interaction is not strong compared to curcumin. These results indicate that curcumin and its didemethyl derivative can be used to modulate proteasome activity and suggest that curcumin and its didemethyl derivative may be useful in treating two different disease classes: neurodegeneration and cancer. Communicated by Ramaswamy H. Sarma
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据